An opportunity for heart failure specialists and allied health professionals to
network, collaborate and support each other in our collective mission to change the
trajectory of heart failure.
The British Society for Heart Failure's Annual Meeting, taking place on 20-21 November 2025 at the QEII Centre, is the heart failure event of the year, bringing together 800 healthcare professionals including consultants, nurses, GPs, physiologists, and other heart failure specialists.
The annual meeting takes place over 2 days as a hybrid event to enable as many healthcare professionals as possible to benefit from this important and educational meeting. We will continue to host the popular workshops, panel discussions and masterclasses, in person and live streamed in multi-media format. This year theme is:
Prevent Today, Thrive Tomorrow
We have invited experts from a number of our affiliated organisations to bring the latest research, innovation, education and updates in heart failure. We aim to increase knowledge and promote research about the diagnosis, causes, management and consequences of heart failure, with the intention of detecting, preventing and delaying the onset of heart failure while improving care for patients with heart failure.
Register for this year’s BSH Annual Meeting to learn how to transform heart failure care across your community to prevent avoidable heart failure deaths through the 25in25 Quality Improvement initiative.
Become a BSH member for discounted ticket prices!
Consultant Cardiologist at St George’s Hospital
Pharmacist in Cardiology at North Bristol NHS Trust
Consultant Cardiologist and HF
Lead at Liverpool University
Hospital
Heart Failure Nurse Consultant at Wiltshire Health
Clinical Lecturer in Cardiology Royal Papworth Hospital and University of Cambridge
20 - 21 November 2025
QEII Conference Centre, London
In-person and online tickets
We are grateful to all our Partners and exhibitors whose funding of exhibition packages have contributed towards this independently produced programme. Exhibitors have not had any editorial input into or control over the agenda, scientific content development or choice of speakers, excluding dedicated industry symposia and masterclasses.